Virtus ETF Advisers’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Virtus ETF Advisers’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-4,226	Closed	-$97K	–	405
2021 Q3	$97K	Sell	4,226 -221	-5%	-$6.58K	0.04%	385
2021 Q2	$195K	Sell	4,447 -2,154	-33%	-$120K	0.08%	361
2021 Q1	$479K	Buy	6,601 +117	+2%	+$8.31K	0.2%	153
2020 Q4	$280K	Buy	6,484 +2,455	+61%	+$110K	0.12%	247
2020 Q3	$166K	Sell	4,029 -550	-12%	-$28.4K	0.09%	311
2020 Q2	$275K	Buy	4,579 +1,668	+57%	+$153K	0.13%	314
2020 Q1	$219K	Sell	2,911 -426	-13%	-$49.1K	0.09%	272
2019 Q4	$459K	Buy	3,337 +1,600	+92%	+$195K	0.08%	214
2019 Q3	$206K	Sell	1,737 -96	-5%	-$13.4K	0.04%	246
2019 Q2	$256K	Buy	+1,833	New	+$322K	0.05%	267

Other funds holding ORTX

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Virtus ETF Advisers's ORTX Position: Q4 2021 in Review

Virtus ETF Advisers sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2021, closing a stake of 4,226 shares — an estimated $97K sold.

Virtus ETF Advisers first reported a position in ORTX in Q2 2019 and held it in 10 quarters. The position peaked at $479K in Q1 2021. 72 funds tracked by Wall St. Rank hold ORTX as of Q4 2021.

Virtus ETF Advisers reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2021 after selling out during the quarter.
Virtus ETF Advisers sold 4,226 Orchard Therapeutics plc American Depositary Shares shares in Q4 2021, an estimated $97K.
Virtus ETF Advisers first reported a position in Orchard Therapeutics plc American Depositary Shares in Q2 2019 and held it in 10 quarters.
Virtus ETF Advisers's Orchard Therapeutics plc American Depositary Shares position peaked at $479K in Q1 2021.
72 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2021.

Based on Virtus ETF Advisers's 13F filing for Q4 2021, filed 14 Feb 2022.